Mifepristone: Many Americans Are Uncertain About Its Safety

However, majorities oppose laws that would restrict access.

View in browser NEW & NOTEWORTHY Many Are Uncertain About the Safety of the Abortion Medication Mifepristone, but Majorities Oppose Laws that Would Restrict Access A new KFF Health Tracking Poll reveals that many Americans remain unfamiliar with key facts about mifepristone, one of two drugs commonly used together in medication abortions, with fewer saying they believe abortion pills are safe now than two years ago. Despite more than two decades of evidence showing mifepristone is safe, fewer than half (42%) of the public now say that abortion pills are safe when taken as directed by a health care provider, down from 55% in May 2023. While fewer (18%) say that abortion pills are unsafe, four in ten say they aren't sure. The results are similar among women ages 18-49 (41% say abortion pills are safe, 21% say they are unsafe, and 37% are not sure). When asked about policies that would restrict access to medication abortion, about two-thirds of the public say they would oppose laws banning the use of medication abortion nationwide or making it a crime for health care providers to mail abortion pills to patients in states where abortion is illegal. Two-thirds also oppose laws banning clinics like Planned Parenthood that provide abortions from receiving federal Medicaid payments for other services they provide, as included in the tax and spending bill enacted into law in July. The poll also finds that few in the public are aware of a new Food and Drug Administration review of the safety of mifepristone announced earlier this fall. Read the findings CONTACT:   Mikhaila Richards | 202.654.1328 | MRichards@kff.org    When citing our work, please note our name is KFF, which is our legal operating name. We should be cited as KFF, a nonprofit health policy research, polling, and news organization. We no longer use the name Kaiser Family Foundation.  Did someone forward this to you? Sign up for emails from KFF. This email was sent to albarkahslamet.ssss@blogger.com. Update your email preferences to choose the types of emails you receive. Or, permanently unsubscribe from all future emails. Need assistance? Email subscriptions@kff.org; do not reply to this email. The independent source for health policy research, polling, and news. KFF, 185 Berry Street, Suite 2000, San Francisco, CA 94107